Pfizer : PFE

All Pfizer Articles

1465 Articles

Douglas A. McIntyre | Jun 21, 2007 at 7:13 PM EDT

NYSE Short Interest, June 2007

The NYSE released short interest in stocks traded on the exchange. The figures are as of June 15 and are…

Douglas A. McIntyre | Jun 21, 2007 at 3:30 AM EDT

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Home Depot (HD) weighed a cut in its credit rating against its decision to buy-back $22.5 billion…

Douglas A. McIntyre | Jun 20, 2007 at 7:39 PM EDT

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Coley Pharmaceuticals (COLY) is yet another small-cap biopharma one-trick pony that fell apart like a cheap clock. Pfizer (PFE) had…

Douglas A. McIntyre | Jun 20, 2007 at 4:37 PM EDT

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM…

Douglas A. McIntyre | Jun 12, 2007 at 5:53 PM EDT

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said…

Douglas A. McIntyre | Jun 8, 2007 at 2:14 PM EDT

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Stock Tickers: AAPL, GOOG, RIMM, BA, UTX, ATI, RTP, RIO, FLR, SGR, PEP, KO, BUD, CAG, HNZ, CPB, HRL, K,…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 22, 2007 at 5:25 PM EDT

DJIA Components Huge Rise in Short Selling (MAY-07)

We reviewed various short selling trends and noticed that most sectors were mixed to up as the April to May…

Douglas A. McIntyre | May 22, 2007 at 4:36 PM EDT

Short Selling Up in Drug & Medical Stocks

Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw…

Douglas A. McIntyre | May 21, 2007 at 6:37 AM EDT

Pre-Market Stock News (May 21, 2007)

(ASD) American Standard is reaffirming guidance.(AT) Alltel agreed to a $27.5 Billion buyout offer, or $71.50 per share.(CATT) Catapult believes…

1 … 96 97 98

Pfizer : PFE

All Pfizer Articles

NYSE Short Interest, June 2007

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Biotechs & Pharmas Bracing For ASCO Annual Meeting

DJIA Components Huge Rise in Short Selling (MAY-07)

Short Selling Up in Drug & Medical Stocks

Pre-Market Stock News (May 21, 2007)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Pfizer : PFE

All Pfizer Articles

NYSE Short Interest, June 2007

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Biotechs & Pharmas Bracing For ASCO Annual Meeting

DJIA Components Huge Rise in Short Selling (MAY-07)

Short Selling Up in Drug & Medical Stocks

Pre-Market Stock News (May 21, 2007)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026